Crocenzi F A, Mottino A D, Roma M G
Instituto de Fisiología Experimental, CONICET - Universidad Nacional de Rosario, Rosario, Argentina.
Curr Med Chem. 2004 Feb;11(4):501-24. doi: 10.2174/0929867043455918.
Bile formation is an osmotic process driven by the vectorial transport of actively transferred biliary components across the basolateral (sinusoidal) and apical (canalicular) hepatocyte membranes, the latter being the rate-limiting step of the overall blood-to-bile transfer. The ATP-binding cassette (ABC) superfamily of membrane transporters comprises novel ATP-dependent carriers that mediate canalicular transfer of several endogenous and exogenous substrates, and therefore play a key role in bile formation. Gene expression, as well as the balance between vesicular targeting and internalization of these transporters to/from the canalicular membrane are highly regulated processes. This balance is affected in several models of hepatocellular cholestasis, and these alterations may either initiate or perpetuate the cholestatic manifestations. This review describes the regulation of the normal activity of hepatocellular ABC transporters, focusing on the involvement of transcription factors and signaling pathways in the regulation of carrier synthesis, dynamic localization and phosphorylation status. Its alteration in different experimental models of cholestasis, such as those induced by estrogens, lipopolysaccharide (endotoxin), monohydroxylated bile salts and oxidative stress, is also reviewed. Finally, several experimental therapeutic approaches based upon the administration of compounds known/thought to induce carrier synthesis (e.g., protein synthesis inducers), to counteract etiological factors responsible for the cholestatic disease (e.g., corticoids in lipopolysaccharide-induced cholestasis) or to stimulate exocytic insertion of canalicular transporters (e.g., cAMP, silymarin or tauroursodeoxycholate) are described with respect to their ability to prevent cholestatic alterations; the role of signaling molecules as putative downstream mediators of their effects are also discussed.
胆汁形成是一个渗透过程,由主动转运的胆汁成分跨肝细胞基底外侧(窦状隙)和顶端(胆小管)膜的矢量转运驱动,后者是整个血液到胆汁转运的限速步骤。膜转运蛋白的ATP结合盒(ABC)超家族包含新型的ATP依赖性载体,这些载体介导几种内源性和外源性底物的胆小管转运,因此在胆汁形成中起关键作用。这些转运蛋白的基因表达以及向胆小管膜的囊泡靶向和从胆小管膜内化之间的平衡是高度受调控的过程。这种平衡在几种肝细胞性胆汁淤积模型中受到影响,这些改变可能引发或延续胆汁淤积的表现。本综述描述了肝细胞ABC转运蛋白正常活性的调控,重点关注转录因子和信号通路在载体合成、动态定位和磷酸化状态调控中的作用。还综述了其在不同胆汁淤积实验模型中的改变,如由雌激素、脂多糖(内毒素)、单羟基胆汁盐和氧化应激诱导的模型。最后,描述了几种基于给予已知/被认为可诱导载体合成的化合物(如蛋白质合成诱导剂)、抵消胆汁淤积性疾病病因(如脂多糖诱导的胆汁淤积中的皮质激素)或刺激胆小管转运蛋白的胞吐插入(如cAMP、水飞蓟素或牛磺熊去氧胆酸)的实验性治疗方法,以及它们预防胆汁淤积改变的能力;还讨论了信号分子作为其作用的假定下游介质的作用。